Form D · Other
ENZYMATICS INC
Beverly, MA · CIK 0000857809
Offering snapshot reported Aug 15, 2013 · SEC filing
- Reported sold
- $3.79M Offering amount: $3.79M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 1, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 15, 2013 | Initial | $3,786,231 | No comparison | 8 | SEC filing |
| Sep 6, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-201385
Source: Form D, filed Aug 15, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Benoit | Director, Executive |
| Paul Manning | Director |
| Jack Percoskie | Executive |
| Stephen Picone | Director, Executive |
| Ian Ratcliffe | Director |
Issuer details
Industry: Other (See others in industry)
Address:
100 Cummings Center Suite 407 J
Beverly, MA, 01915
Beverly, MA, 01915